切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2020, Vol. 06 ›› Issue (03) : 196 -199. doi: 10.3877/cma.j.issn.2095-9605.2020.03.011

所属专题: 文献

综述

幽门螺杆菌感染与肥胖症相关性的研究进展
玉素甫·托合提1, 李可1,()   
  1. 1. 830001 乌鲁木齐,新疆医科大学第五附属医院消化内科
  • 收稿日期:2020-04-25 出版日期:2020-08-30
  • 通信作者: 李可

Research progress on the relationship between Helicobacter pylori infection and obesity

Tuoheti Yusufu·1, Ke Li1()   

  • Received:2020-04-25 Published:2020-08-30
  • Corresponding author: Ke Li
引用本文:

玉素甫·托合提, 李可. 幽门螺杆菌感染与肥胖症相关性的研究进展[J]. 中华肥胖与代谢病电子杂志, 2020, 06(03): 196-199.

Tuoheti Yusufu·, Ke Li. Research progress on the relationship between Helicobacter pylori infection and obesity[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2020, 06(03): 196-199.

[1]
Zhang F, Chen C, Hu J, et al. Molecular mechanism of Helicobacter pyloriinduced autophagy in gastric cancer[J]. Oncology Letters, 2019,18(6): 6221-6227.
[2]
Sabbagh P, Sabbagh P, Mohammadnia-Afrouzi M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38(1): 55-66.
[3]
Marshall B, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration[J]. The Lancet, 1984, 323(8390): 1311-1315.
[4]
Mantovani A, Turino T, Altomari A, et al. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis[J]. Metabolism, 2019, 96: 56-65.
[5]
Lim SH, Kim N, Kwon JW, et al. Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study[J]. Digestive Diseases and Sciences, 2019, 64(8): 2219-2230.
[6]
Chen L, Kuo S, Chen C, et al. A community-based study on the association between Helicobacter pylori Infection and obesity[J]. Scientific Reports, 2018, 8(1): 1-10.
[7]
World Health Organization.Obesity and overweight[EB/OL]. Geneva: WHO,2015.

URL    
[8]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会.中国儿童和青少年肥胖症外科治疗指南(2019版)[J/CD].中华肥胖与代谢病电子杂志,2019,5(1):3-9.
[9]
De Pergola G, Silvestris F. Obesity as a Major Risk Factor for Cancer[J]. Journal of Obesity, 2013, 2013: 1-11.
[10]
Ahirwar R, Mondal PR. Prevalence of obesity in India: A systematic review[J]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019, 13(1): 318-321.
[11]
Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis[J]. Gastroenterology, 2017, 153(2): 420-429.
[12]
Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections[J]. Obesity Reviews, 2015, 16(12): 1017-1029.
[13]
Xu X, Li W, Qin L, et al. Relationship between Helicobacter pylori infection and obesity in Chinese adults: A systematic review with meta-analysis[J]. PLOS ONE, 2019, 14(9): e221076.
[14]
Hamada M, Nomura R, Ogaya Y, et al. Potential involvement of Helicobacter pylori from oral specimens in overweight body-mass index[J]. Scientific Reports, 2019, 9(1): 1-9.
[15]
Moran-Lev H, Lubetzky R, Mandel D, et al. Inverse Correlation between Helicobacter pylori Colonization and Pediatric Overweight: A Preliminary Study[J]. Childhood Obesity, 2017, 13(4): 267-271.
[16]
Mera RM, Bravo LE, Goodman KJ, et al. Long-term Effects of Clearing Helicobacter pylori on Growth in School-age Children[J]. The Pediatric Infectious Disease Journal, 2012, 31(3): 263-266.
[17]
Arslan E, Atılgan H, Yavaşoğlu İ. The prevalence of Helicobacter pylori in obese subjects[J]. European Journal of Internal Medicine, 2009, 20(7): 695-697.

URL    
[18]
Erim T, Cruz-Correa RM,, et al. prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: A Preliminary Study[J]. World journal of surgery, 2008, 32(9): 2021-2025.

URL    
[19]
Wu M, Lee W, Wang H, et al. A Case-Control Study of Association of Helicobacter pylori Infection With Morbid Obesity in Taiwan[J]. Archives of internal medicine, 2005, 165(13): 1552-1555.
[20]
Emile SH, Elshobaky A, Elbanna HG, et al. Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease; Is there a Relation?[J]. Obesity Surgery, 2020, 30: 3037-3045.
[21]
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society[J]. Obesity, 2013, 21(S1): S1-S27.
[22]
Keren D, Matter I, Rainis T, et al. Sleeve Gastrectomy Leads to Helicobacter pylori Eradication[J]. Obesity Surgery, 2009, 19(6): 751-756.

URL    
[23]
Chen J, Ma J, Liu X, et al. The association between Helicobacter pylori infection with overweight/obesity[J]. Medicine, 2020, 99(3): e18703.
[24]
Winer DA, Luck H, Tsai S, et al. The Intestinal Immune System in Obesity and Insulin Resistance[J]. Cell Metabolism, 2016, 23(3): 413-426.
[25]
Torres S, Fabersani E, Marquez A, et al. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics[J]. European Journal of Nutrition, 2019, 58(1): 27-43.
[26]
Hong C, Park A, Yang B, et al. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice[J]. Gastroenterology, 2017, 152(8): 1998-2010.
[27]
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance[J]. Annu Rev Physiol, 2010, 72: 219-246.
[28]
Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease[J]. Nature Medicine, 2012, 18(3): 363-374.

URL    
[29]
Upala S, Sanguankeo A, Saleem SA, et al. Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters[J]. European Journal of Gastroenterology & Hepatology, 2017, 29(2): 153-159.
[30]
Hills RD, Pontefract BA, Mishcon HR, et al. Gut Microbiome: Profound Implications for Diet and Disease[J]. Nutrients, 2019, 11(7): 1613.
[31]
Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature, 2006, 444(7122): 1027-1031.
[32]
Llorca L, Pérez-Pérez G, Urruzuno P, et al. Characterization of the Gastric Microbiota in a Pediatric Population According to Helicobacter pylori Status[J]. The Pediatric Infectious Disease Journal, 2017, 36(2): 173-178.
[33]
Rastelli M, Knauf C, Cani PD. Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders[J]. Obesity, 2018, 26(5): 792-800.
[34]
Polyzos SA, Kountouras J, Zavos C, et al. The association between Helicobacter pylori infection and insulin resistance: a systematic review[J]. Helicobacter, 2011, 16(2): 79-88.

URL    
[35]
Suki M, Leibovici Weissman Y, Boltin D, et al. Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders[J]. European Journal of Gastroenterology & Hepatology, 2018, 30(2): 143-148.
[36]
He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics[J]. Cell & Bioscience, 2017, 7(1): 54.
[37]
Thiennimitr P, Yasom S, Tunapong W, et al. Lactobacillus paracasei HII01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats[J]. Nutrition, 2018, 54: 40-47.
[38]
Dehghani SM, Karamifar H, Raeesi T, et al. Growth parameters in children with dyspepsia symptoms and Helicobacter pylori infection[J]. Indian Pediatr, 2013, 50(3): 324-326.

URL    
[39]
Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin[J]. Nature, 1998, 394(6695): 790-793.
[40]
Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review[J]. Obesity Reviews, 2007, 8(1): 21-34.
[41]
Rosenbaum M, Leibel RL. 20 YEARS OF LEPTIN: Role of leptin in energy homeostasis in humans[J]. Journal of Endocrinology, 2014, 223(1): T83-T96.

URL    
[42]
Roper J, Francois F, Shue PL, et al. Leptin and Ghrelin in Relation to Helicobacter pylori Status in Adult Males[J]. The Journal of Clinical Endocrinology & Metabolism, 2008, 93(6): 2350-2357.
[43]
Khosravi Y, Seow SW, Amoyo AA, et al. Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice[J]. Scientific Reports, 2015, 5(1): 8731.
[44]
Yang Y. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels[J]. World Journal of Gastroenterology, 2012,18(21):2674-2681.

URL    
[45]
Freshwater DA, O'Hare P, Randeva HS, et al. Plasma ghrelin following cure of Helicobacter pylori[J]. Gastroenterology, 2003, 124(4): A122-A123.
[46]
Xu M, Liu L, Yuan B, et al. Association of obesity withHelicobacter pylori infection: A retrospective study[J]. World Journal of Gastroenterology, 2017,23(15):2750.
[47]
Carabotti M. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery[J]. World Journal of Gastroenterology, 2014, 20(3): 647-653.

URL    
[48]
Mayerle J, den Hoed CM, Schurmann C, et al. Identification of Genetic Loci Associated With Helicobacter pylori Serologic Status[J]. JAMA, 2013, 309(18): 1912-1920.
[49]
Pigeyre M, Yazdi FT, Kaur Y, et al. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity[J]. Clinical Science, 2016, 130(12): 943-986.
[1] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[2] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[3] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[4] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[5] 李晓晖, 上官昌盛, 向英, 裴芝皆, 车俊志, 谢飞. 3D腹腔镜袖状胃切除术后机体能量代谢与多囊卵巢综合征患者性激素水平关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 538-541.
[6] 安钱, 徐彬, 陈志祥, 徐晶晶, 黄丹丹. PCT、CRP及SAA对呼吸机相关性肺炎病情严重程度和预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 544-546.
[7] 潘春江, 李科, 李新楼, 杨博, 任雪玲. 高龄老人骨转换代谢标志物与肾功能的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(05): 260-264.
[8] 张瑞琪, 张丽娟, 孙斌. 甲状腺相关性眼病表观遗传学的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 226-230.
[9] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[10] 赵军, 李超杰, 李佳. 雷贝拉唑联合康复新液对治疗幽门螺杆菌阳性的十二指肠溃疡的疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 254-258.
[11] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[12] 董青, 丁飞, 郭浩, 李峰. Nesfatin-1/NUCB2在幽门螺杆菌感染相关早期胃癌患者中的表达及临床意义[J]. 中华临床医师杂志(电子版), 2023, 17(07): 783-789.
[13] 魏红涛, 普布仓决, 格桑央宗, 黎燕, 益西旺扎, 李鹏. 拉萨地区上消化道溃疡患者幽门螺杆菌感染及治疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 662-665.
[14] 陈捷, 白易, 刘金波, 刘欢, 赵娜, 赵红薇, 王宏宇. 中老年人群中性粒细胞和高密度脂蛋白比值与下肢动脉疾病的相关性[J]. 中华临床医师杂志(电子版), 2023, 17(04): 402-408.
[15] 高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平. 一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 258-263.
阅读次数
全文


摘要